| Term 
 
        |         Treatment of Iron Deficiency Anemia |  | Definition 
 
        |       PO is recommended route (if tolerated) Response begins in 7-10 days Hgb will rise about 1 g/dL per week Re-evaluate if Hgb does NOT ↑ by 2 g/dL in 3 weeks |  | 
        |  | 
        
        | Term 
 
        |         Dosage of Elemental Iron for Treatment of Iron Deficiency Anemia |  | Definition 
 
        |       200 mg daily (2 - 3 doses/day) Take on empty stomach for max absorption (↑ absorption with vitamin C) GI AE may prevent patient from taking on empty stomach |  | 
        |  | 
        
        | Term 
 
        |         Types of PO Fe Supplements |  | Definition 
 
        |     Ferrous Sulfate (Feosol®) Ferrous Gluconate (Fergon®) Ferrous Fumarate (Feostat®) Polysaccharide-iron Complex (Niferex®) |  | 
        |  | 
        
        | Term 
 
        |         Adverse effects of PO Fe Supplementation |  | Definition 
 
        |     Abdominal pain Nausea Dyspepsia/heartburn Constipation Dark stools |  | 
        |  | 
        
        | Term 
 
        |         Drug Interactions with PO Fe Supplementation |  | Definition 
 
        |       Forms bonds (↓ absorption of other meds) FQs, Tetracyclines, Phenytoin Separate the interacting drug by 2-4 hours |  | 
        |  | 
        
        | Term 
 
        |         Black Box for PO Fe Supplementation |  | Definition 
 
        |         Iron toxicity - severe toxicity may occur in overdose, particularly when ingested by children; iron is a leading cause of fatal poisoning in children; store out of children's reach and in child-resistant containers |  | 
        |  | 
        
        | Term 
 
        |         Use of Parenteral Fe Supplementation |  | Definition 
 
        |         Iron deficiency anemia & unable to tolerate PO Fe or have failed PO Fe therapy (malabsorption) |  | 
        |  | 
        
        | Term 
 
        |         Use of Iron Dextran (InFED) 50 mg/mL |  | Definition 
 
        |       Given as IV infusion or IM injection IM injections: Z-track & staining of skin Black box warning: test dosing for allergic reaction |  | 
        |  | 
        
        | Term 
 
        |         Newer formulations of parenteral Fe supplements |  | Definition 
 
        |       Approved for anemia associated with CKD Less adverse effects (allergenicity) but very expensive Iron sucrose (Venofer) Sodium ferric gluconate (Ferrlecit) |  | 
        |  | 
        
        | Term 
 
        |         Treatment of vitamin B12 Deficiency |  | Definition 
 
        |   Vitamin B12 (Cyanocobalmin) Route: PO, parenteral PO: Poor absorption Parenteral: complete absorption (works without intrinsic factor) - Deep SQ injection, IM injection - Dosing daily x 1 week, weekly, then monthly for life |  | 
        |  | 
        
        | Term 
 
        |         Intranasal treatment of Vitamin B12 deficiency |  | Definition 
 
        |       Nascobal - vitamin B12 nasal spray 500 mcg/spray Dosing & administration - Initial dose is one spray 500 mcg in ONE nostril once weekly |  | 
        |  | 
        
        | Term 
 
        |         Response to treatment of vitamin B12 deficiency |  | Definition 
 
        |     Neurologic symptoms & megaloblastic cells begin resolving within a few days & Hgb levels begin to ↑ after 1 week of therapy |  | 
        |  | 
        
        | Term 
 
        |         Adverse effects to treatment of vitamin B12 deficiency |  | Definition 
 
        |         Injection: injection site reaction, rash, pruritis Nasal: rhinitis; nasal irritation |  | 
        |  | 
        
        | Term 
 
        |         Use of PO Treatment of Folic Acid Deficiency |  | Definition 
 
        |     
 
Initial dose of 1 mg/day (malabsorption requires ↑ dosages)Response - Rapid resolution of symptoms & reticulocytosisHgb begins to rise after about 2 weeks of therapy, do treatment for 2-4 months |  | 
        |  | 
        
        | Term 
 
        |         Adverse effects and drug interactions of PO Folic Acid for Folic Acid Deficiency |  | Definition 
 
        |   AEs: Allergic reactions, flushing, rash   DIs: Phenytoin (↓ phenytoin levels)   Drug-disease interaction: may obscure dx in pernicious anemia (vitamin B12) |  | 
        |  | 
        
        | Term 
 
        |         Parenteral Treatment of Folic Acid Deficiency |  | Definition 
 | 
        |  | 
        
        | Term 
 
        |         Dosing of Erythropoietin Products |  | Definition 
 
        |   
 
Titrating schedule based labs & type/severity of anemiaHgb at least every 2 weeks with adjustment of dosingPatients should also be assessed for Fe deficiency anemia (adequate Fe stores are required)Discontinue: Hgb > 12 g/dL & restart if Hgb < 12 g/dL |  | 
        |  | 
        
        | Term 
 
        |         Use of erythropoietin products for patients with CKD |  | Definition 
 
        |         Recommended to start CKD patients on treatment in the earlier stages of CKD Slowed disease progression with initiation of earlier treatment |  | 
        |  |